| Testosterone-undecanoate | hsa00020 | Citrate cycle (TCA cycle) | 3.41E-02 | 2 | P50213, O14521 | IDH3A, SDHD | More | |
| Testosterone-undecanoate | hsa00040 | Pentose and glucuronate interconversions | 3.53E-02 | 1 | O60701 | UGDH | More | |
| Testosterone-undecanoate | hsa00190 | Oxidative phosphorylation | 4.36E-03 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | |
| Testosterone-undecanoate | hsa00340 | Histidine metabolism | 4.52E-02 | 1 | O95954 | FTCD | More | |
| Testosterone-undecanoate | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.11E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | |
| Testosterone-undecanoate | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 1.91E-02 | 1 | Q9NY97 | B3GNT2 | More | |
| Testosterone-undecanoate | hsa00564 | Glycerophospholipid metabolism | 9.70E-03 | 2 | Q9Y259, P49619 | CHKB, DGKG | More | |
| Testosterone-undecanoate | hsa00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 3.78E-02 | 1 | Q9NY97 | B3GNT2 | More | |
| Testosterone-undecanoate | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 8.72E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | |
| Testosterone-undecanoate | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 2.46E-02 | 2 | P06865, Q9H4F1 | HEXA, ST6GALNAC4 | More | |
| Testosterone-undecanoate | hsa01100 | Metabolic pathways | 2.25E-02 | 7 | Q9Y259, Q13956, P49619, O95954, Q02318, Q9UBX8, P35573 | CHKB, PDE6H, DGKG, FTCD, CYP27A1, B4GALT6, AGL | More | |
| Testosterone-undecanoate | hsa01210 | 2-Oxocarboxylic acid metabolism | 6.96E-04 | 1 | P50213 | IDH3A | More | |
| Testosterone-undecanoate | hsa01230 | Biosynthesis of amino acids | 3.91E-02 | 3 | P51854, Q99707, P50213 | TKTL1, MTR, IDH3A | More | |
| Testosterone-undecanoate | hsa01240 | Biosynthesis of cofactors | 2.05E-02 | 2 | P36551, O60701 | CPOX, UGDH | More | |
| Testosterone-undecanoate | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa01522 | Endocrine resistance | 2.16E-02 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa03013 | RNA transport | 8.18E-05 | 9 | P38919, Q15287, Q9UBU9, P37198, P35658, P63279, P55884, O15371, P20042 | EIF4A3, RNPS1, NXF1, NUP62, NUP214, UBE2I, EIF3B, EIF3D, EIF2S2 | More | |
| Testosterone-undecanoate | hsa03040 | Spliceosome | 3.98E-02 | 4 | Q15427, P38159, P61978, P11142 | SF3B4, RBMX, HNRPK, HSPA8 | More | |
| Testosterone-undecanoate | hsa03060 | Protein export | 1.13E-03 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | |
| Testosterone-undecanoate | hsa03320 | PPAR signaling pathway | 2.42E-03 | 4 | Q6PCB7, Q9UNU6, Q13133, Q02318 | SLC27A1, CYP8B1, NR1H3, CYP27A1 | More | |
| Testosterone-undecanoate | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa04012 | ErbB signaling pathway | 2.98E-03 | 6 | P21860, P16333, Q13557, P19174, O14944, P01106 | ERBB3, NCK1, CAMK2D, PLCG1, EREG, MYC | More | |
| Testosterone-undecanoate | hsa04014 | Ras signaling pathway | 3.65E-02 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa04015 | Rap1 signaling pathway | 2.99E-02 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa04020 | Calcium signaling pathway | 6.50E-04 | 6 | Q96DU7, P45880, Q13557, P21860, P51828, P23634 | ITPKC, VDAC2, CAMK2D, ERBB3, ADCY7, ATP2B4 | More | |
| Testosterone-undecanoate | hsa04022 | cGMP-PKG signaling pathway | 4.72E-02 | 4 | Q99941, P23634, P51828, P45880 | CREBL1, ATP2B4, ADCY7, VDAC2 | More | |
| Testosterone-undecanoate | hsa04060 | Cytokine-cytokine receptor interaction | 3.20E-02 | 3 | P37173, P78552, P80075 | TGFBR2, IL13RA1, CCL8 | More | |
| Testosterone-undecanoate | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 2.60E-02 | 3 | Q8NHW4, P61073, Q13651 | CCL4L2, CXCR4, IL10RA | More | |
| Testosterone-undecanoate | hsa04064 | NF-kappa B signaling pathway | 4.06E-06 | 16 | P10415, Q13489, O00463, Q13546, P01584, Q04759, Q9UDY8, P67870, Q16548, Q13315, P63279, P24522, Q8NHW4, P09341, Q9UNE0, Q9NQC7 | BCL2, BIRC3, TRAF5, RIPK1, IL1B, PRKCQ, MALT1, CSNK2B, BCL2A1, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, EDAR, CYLD | More | |
| Testosterone-undecanoate | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa04070 | Phosphatidylinositol signaling system | 2.96E-02 | 3 | P19174, P49619, P27987 | PLCG1, DGKG, ITPKB | More | |
| Testosterone-undecanoate | hsa04071 | Sphingolipid signaling pathway | 1.19E-02 | 5 | P21453, Q9H228, Q13362, Q9BX95, P10415 | S1PR1, EDG8, PPP2R5C, SGPP1, BCL2 | More | |
| Testosterone-undecanoate | hsa04080 | Neuroactive ligand-receptor interaction | 1.00E-02 | 7 | P08311, Q15722, P21453, Q9H228, O00398, P21730, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, ADRB2 | More | |
| Testosterone-undecanoate | hsa04110 | Cell cycle | 1.65E-04 | 8 | Q9UBD5, P06493, O75293, P30304, P33981, P42773, P01106, Q13547 | ORC3, CDK1, GADD45B, CDC25A, TTK, CDKN2C, MYC, HDAC1 | More | |
| Testosterone-undecanoate | hsa04114 | Oocyte meiosis | 6.20E-06 | 6 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0, P08069 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4, IGF1R | More | |
| Testosterone-undecanoate | hsa04140 | Autophagy - animal | 2.95E-02 | 5 | P08069, P22694, Q14643, P10415, Q04759 | IGF1R, PRKACB, ITPR1, BCL2, PRKCQ | More | |
| Testosterone-undecanoate | hsa04141 | Protein processing in endoplasmic reticulum | 2.01E-03 | 8 | P07384, O95487, Q99941, O75460, P11142, Q9H3Z4, P07900, O95816 | CAPN1, SEC24B, CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1, BAG2 | More | |
| Testosterone-undecanoate | hsa04145 | Phagosome | 4.48E-02 | 5 | Q15080, P05164, O60603, P35443, P13765 | NCF4, MPO, TLR2, THBS4, HLA-DOB | More | |
| Testosterone-undecanoate | hsa04150 | mTOR signaling pathway | 7.74E-03 | 4 | P08069, Q02750, Q9NQL2, P51812 | IGF1R, MAP2K1, RRAGD, RPS6KA3 | More | |
| Testosterone-undecanoate | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa04210 | Apoptosis | 3.44E-02 | 7 | Q13315, P10415, O76075, P24522, Q16548, P43234, Q14643 | ATM, BCL2, DFFB, GADD45A, BCL2A1, CTSO, ITPR1 | More | |
| Testosterone-undecanoate | hsa04211 | Longevity regulating pathway | 1.34E-03 | 4 | Q12778, P08069, Q9UEF7, Q96KQ7 | FOXO1, IGF1R, KL, EHMT2 | More | |
| Testosterone-undecanoate | hsa04213 | Longevity regulating pathway - multiple species | 1.66E-02 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa04217 | Necroptosis | 2.93E-02 | 3 | P01568, Q13489, Q13546 | IFNA21, BIRC3, RIPK1 | More | |
| Testosterone-undecanoate | hsa04260 | Cardiac muscle contraction | 4.49E-02 | 3 | P67936, P13073, P12074 | TPM4, COX4I1, COX6A1 | More | |
| Testosterone-undecanoate | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.98E-02 | 4 | P51828, Q99941, Q13557, P23634 | ADCY7, CREBL1, CAMK2D, ATP2B4 | More | |
| Testosterone-undecanoate | hsa04330 | Notch signaling pathway | 2.46E-03 | 3 | Q92542, P49768, P46531 | NCSTN, PSEN1, NOTCH1 | More | |
| Testosterone-undecanoate | hsa04340 | Hedgehog signaling pathway | 3.09E-02 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | |
| Testosterone-undecanoate | hsa04360 | Axon guidance | 1.50E-02 | 3 | P20827, P23528, Q06124 | EFNA1, CFL1, PTPN11 | More | |
| Testosterone-undecanoate | hsa04370 | VEGF signaling pathway | 7.07E-07 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | |
| Testosterone-undecanoate | hsa04390 | Hippo signaling pathway | 4.35E-02 | 2 | P63261, O15105 | ACTG1, SMAD7 | More | |
| Testosterone-undecanoate | hsa04392 | Hippo signaling pathway - multiple species | 3.01E-02 | 1 | Q6V0I7 | FAT4 | More | |
| Testosterone-undecanoate | hsa04510 | Focal adhesion | 3.48E-02 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa04520 | Adherens junction | 8.29E-03 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa04530 | Tight junction | 2.17E-03 | 3 | P63261, Q9Y478, Q92974 | ACTG1, PRKAB1, ARHGEF2 | More | |
| Testosterone-undecanoate | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 9.61E-03 | 4 | Q13873, Q02750, P08069, Q86SE9 | BMPR2, MAP2K1, IGF1R, PCGF5 | More | |
| Testosterone-undecanoate | hsa04612 | Antigen processing and presentation | 5.83E-03 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | |
| Testosterone-undecanoate | hsa04613 | Neutrophil extracellular trap formation | 3.04E-03 | 13 | P19174, P11215, O60603, P05164, P08246, Q9UM07, Q13547, P62807, Q16778, Q15080, P20160, P08311, P21730 | PLCG1, ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, HIST1H2BC, HIST2H2BE, NCF4, AZU1, CTSG, C5AR1 | More | |
| Testosterone-undecanoate | hsa04620 | Toll-like receptor signaling pathway | 4.16E-02 | 2 | Q13546, P01568 | RIPK1, IFNA21 | More | |
| Testosterone-undecanoate | hsa04621 | NOD-like receptor signaling pathway | 4.48E-03 | 12 | P01568, Q13489, Q9H1Y0, P43490, O00463, Q13546, Q05823, P01375, P49913, P59665, P59666, P12838 | IFNA21, BIRC3, ATG5, PBEF1, TRAF5, RIPK1, RNASEL, TNF, CAMP, DEFA1; DEFA1B, DEFA3, DEFA4 | More | |
| Testosterone-undecanoate | hsa04622 | RIG-I-like receptor signaling pathway | 2.39E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | |
| Testosterone-undecanoate | hsa04623 | Cytosolic DNA-sensing pathway | 8.25E-05 | 4 | P01584, P01568, Q13546, Q8NHW4 | IL1B, IFNA21, RIPK1, CCL4L2 | More | |
| Testosterone-undecanoate | hsa04630 | JAK-STAT signaling pathway | 3.20E-02 | 4 | P01106, P42224, P14784, Q13651 | MYC, STAT1, IL2RB, IL10RA | More | |
| Testosterone-undecanoate | hsa04650 | Natural killer cell mediated cytotoxicity | 6.65E-06 | 11 | P16298, P50591, P01375, O60880, P20963, Q02750, Q13241, P26718, O75015, P26717, P26715 | PPP3CB, TNFSF10, TNF, SH2D1A, CD247, MAP2K1, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | |
| Testosterone-undecanoate | hsa04658 | Th1 and Th2 cell differentiation | 5.56E-10 | 14 | Q04759, P07766, P20963, P09693, P19174, P01730, P06239, P42224, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, PLCG1, CD4, LCK, STAT1, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | |
| Testosterone-undecanoate | hsa04659 | Th17 cell differentiation | 5.67E-06 | 12 | Q04759, P19174, P01730, P06239, P42224, P14784, P13765, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, PLCG1, CD4, LCK, STAT1, IL2RB, HLA-DOB, TBX21, GATA3, CD3E, CD3G, CD247 | More | |
| Testosterone-undecanoate | hsa04660 | T cell receptor signaling pathway | 1.22E-03 | 12 | Q9UDY8, Q04759, P10747, Q08881, P19174, P16333, P07766, P20963, P09693, P01730, P01732, P06239 | MALT1, PRKCQ, CD28, ITK, PLCG1, NCK1, CD3E, CD247, CD3G, CD4, CD8A, LCK | More | |
| Testosterone-undecanoate | hsa04668 | TNF signaling pathway | 4.74E-02 | 3 | Q99941, P01584, O95429 | CREBL1, IL1B, BAG4 | More | |
| Testosterone-undecanoate | hsa04714 | Thermogenesis | 1.25E-02 | 3 | P15336, P63261, Q9Y478 | ATF2, ACTG1, PRKAB1 | More | |
| Testosterone-undecanoate | hsa04720 | Long-term potentiation | 9.52E-04 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | |
| Testosterone-undecanoate | hsa04721 | Synaptic vesicle cycle | 1.80E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | |
| Testosterone-undecanoate | hsa04730 | Long-term depression | 1.16E-02 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa04750 | Inflammatory mediator regulation of TRP channels | 3.74E-02 | 3 | P01584, P51828, Q13557 | IL1B, ADCY7, CAMK2D | More | |
| Testosterone-undecanoate | hsa04911 | Insulin secretion | 1.48E-02 | 3 | P51828, Q99941, Q13557 | ADCY7, CREBL1, CAMK2D | More | |
| Testosterone-undecanoate | hsa04913 | Ovarian steroidogenesis | 1.16E-02 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa04914 | Progesterone-mediated oocyte maturation | 1.86E-05 | 5 | P08069, Q17RY0, Q9Y6D9, P51812, Q02750 | IGF1R, CPEB4, MAD1L1, RPS6KA3, MAP2K1 | More | |
| Testosterone-undecanoate | hsa04915 | Estrogen signaling pathway | 4.72E-02 | 4 | Q99941, P51828, P07900, P11142 | CREBL1, ADCY7, HSP90AA1, HSPA8 | More | |
| Testosterone-undecanoate | hsa04919 | Thyroid hormone signaling pathway | 1.64E-02 | 4 | P19174, P42224, Q13547, P01106 | PLCG1, STAT1, HDAC1, MYC | More | |
| Testosterone-undecanoate | hsa04920 | Adipocytokine signaling pathway | 2.80E-02 | 2 | Q06124, Q9Y478 | PTPN11, PRKAB1 | More | |
| Testosterone-undecanoate | hsa04922 | Glucagon signaling pathway | 4.23E-02 | 4 | P22694, P06737, Q12778, Q14643 | PRKACB, PYGL, FOXO1, ITPR1 | More | |
| Testosterone-undecanoate | hsa04924 | Renin secretion | 1.04E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | |
| Testosterone-undecanoate | hsa04925 | Aldosterone synthesis and secretion | 5.19E-03 | 4 | Q99941, P51828, Q13557, P23634 | CREBL1, ADCY7, CAMK2D, ATP2B4 | More | |
| Testosterone-undecanoate | hsa04928 | Parathyroid hormone synthesis, secretion and action | 4.23E-02 | 4 | Q14643, P22694, P23771, P10415 | ITPR1, PRKACB, GATA3, BCL2 | More | |
| Testosterone-undecanoate | hsa04932 | Non-alcoholic fatty liver disease | 1.24E-02 | 6 | O43521, O75460, P01584, P13073, P12074, O15239 | BCL2L11, ERN1, IL1B, COX4I1, COX6A1, NDUFA1 | More | |
| Testosterone-undecanoate | hsa04934 | Cushing syndrome | 3.48E-03 | 4 | Q99941, P51828, O15169, Q13557 | CREBL1, ADCY7, AXIN1, CAMK2D | More | |
| Testosterone-undecanoate | hsa04971 | Gastric acid secretion | 1.48E-02 | 3 | P51828, P15311, Q13557 | ADCY7, VIL2, CAMK2D | More | |
| Testosterone-undecanoate | hsa04975 | Fat digestion and absorption | 2.80E-02 | 1 | O14494 | PLPP1 | More | |
| Testosterone-undecanoate | hsa05010 | Alzheimer disease | 1.56E-03 | 14 | Q92542, O15239, P05496, P13073, P12074, Q00535, O75460, P0DP23, P01584, O95197, O15169, P67870, P45880, P28070 | NCSTN, NDUFA1, ATP5G1, COX4I1, COX6A1, CDK5, ERN1, CALM1, IL1B, RTN3, AXIN1, CSNK2B, VDAC2, PSMB4 | More | |
| Testosterone-undecanoate | hsa05020 | Prion disease | 1.81E-02 | 7 | P01584, P46531, P11142, P05496, P12074, P45880, Q99941 | IL1B, NOTCH1, HSPA8, ATP5G1, COX6A1, VDAC2, CREBL1 | More | |
| Testosterone-undecanoate | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.95E-02 | 2 | Q06055, O15020 | ATP5G2, SPTBN2 | More | |
| Testosterone-undecanoate | hsa05034 | Alcoholism | 4.79E-02 | 3 | Q13547, P62807, Q16778 | HDAC1, HIST1H2BC, HIST2H2BE | More | |
| Testosterone-undecanoate | hsa05100 | Bacterial invasion of epithelial cells | 2.85E-02 | 3 | Q14141, Q05397, Q96JJ3 | SEPT6, PTK2, ELMO2 | More | |
| Testosterone-undecanoate | hsa05130 | Pathogenic Escherichia coli infection | 9.80E-03 | 4 | Q92974, P63261, Q06124, O95487 | ARHGEF2, ACTG1, PTPN11, SEC24B | More | |
| Testosterone-undecanoate | hsa05132 | Salmonella infection | 9.85E-03 | 4 | Q13546, Q13489, O60282, P68371 | RIPK1, BIRC3, KIF5C, TUBB2C | More | |
| Testosterone-undecanoate | hsa05135 | Yersinia infection | 3.29E-02 | 4 | Q05397, P51812, Q02750, Q96JJ3 | PTK2, RPS6KA3, MAP2K1, ELMO2 | More | |
| Testosterone-undecanoate | hsa05140 | Leishmaniasis | 4.50E-03 | 5 | P14598, O60603, P25963, P29350, Q15080 | NCF1, TLR2, NFKBIA, PTPN6, NCF4 | More | |
| Testosterone-undecanoate | hsa05144 | Malaria | 3.12E-02 | 4 | P60033, P01375, P35443, P26718 | CD81, TNF, THBS4, KLRK1 | More | |
| Testosterone-undecanoate | hsa05150 | Staphylococcus aureus infection | 1.02E-03 | 7 | P21730, P21462, O75015, P59665, P59666, P12838, P49913 | C5AR1, FPR1, FCGR3B, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | |
| Testosterone-undecanoate | hsa05163 | Human cytomegalovirus infection | 2.89E-02 | 7 | P0DP23, Q8NHW4, Q08828, P23458, P01584, P61073, Q13651 | CALM1, CCL4L2, ADCY1, JAK1, IL1B, CXCR4, IL10RA | More | |
| Testosterone-undecanoate | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.94E-02 | 4 | P62879, P16298, Q02750, P0CG47 | GNB2, PPP3CB, MAP2K1, UBB | More | |
| Testosterone-undecanoate | hsa05169 | Epstein-Barr virus infection | 3.66E-02 | 5 | P01106, Q13547, Q13761, P42224, P07766 | MYC, HDAC1, RUNX3, STAT1, CD3E | More | |
| Testosterone-undecanoate | hsa05170 | Human immunodeficiency virus 1 infection | 6.02E-03 | 5 | Q02750, P62879, P16298, Q05397, P20333 | MAP2K1, GNB2, PPP3CB, PTK2, TNFRSF1B | More | |
| Testosterone-undecanoate | hsa05202 | Transcriptional misregulation in cancer | 2.48E-03 | 10 | Q12778, Q13315, P14780, Q16548, O15550, P08069, P05164, P08246, Q9C0K0, P24522 | FOXO1, ATM, MMP9, BCL2A1, UTX, IGF1R, MPO, ELA2, BCL11B, GADD45A | More | |
| Testosterone-undecanoate | hsa05203 | Viral carcinogenesis | 9.16E-03 | 5 | Q13547, P12814, P06493, P62807, Q16778 | HDAC1, ACTN1, CDK1, HIST1H2BC, HIST2H2BE | More | |
| Testosterone-undecanoate | hsa05205 | Proteoglycans in cancer | 3.48E-02 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa05206 | MicroRNAs in cancer | 2.97E-03 | 6 | P15311, P21860, P61978, P46531, P63279, P22105 | VIL2, ERBB3, HNRPK, NOTCH1, UBE2I, TNXB | More | |
| Testosterone-undecanoate | hsa05210 | Colorectal cancer | 3.43E-02 | 2 | Q9UKG1, P37173 | APPL1, TGFBR2 | More | |
| Testosterone-undecanoate | hsa05211 | Renal cell carcinoma | 1.06E-02 | 2 | Q06124, Q99814 | PTPN11, EPAS1 | More | |
| Testosterone-undecanoate | hsa05213 | Endometrial cancer | 3.79E-02 | 2 | O15169, Q02750 | AXIN1, MAP2K1 | More | |
| Testosterone-undecanoate | hsa05214 | Glioma | 9.95E-03 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa05215 | Prostate cancer | 1.33E-02 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa05218 | Melanoma | 6.63E-03 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa05223 | Non-small cell lung cancer | 4.24E-02 | 3 | P19174, Q9HC35, O75293 | PLCG1, EML4, GADD45B | More | |
| Testosterone-undecanoate | hsa05224 | Breast cancer | 1.49E-02 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa05225 | Hepatocellular carcinoma | 1.33E-02 | 1 | P08069 | IGF1R | More | |
| Testosterone-undecanoate | hsa05226 | Gastric cancer | 3.79E-02 | 2 | Q02750, O15169 | MAP2K1, AXIN1 | More | |
| Testosterone-undecanoate | hsa05231 | Choline metabolism in cancer | 1.14E-04 | 3 | Q9Y259, P19174, P49619 | CHKB, PLCG1, DGKG | More | |
| Testosterone-undecanoate | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.20E-06 | 11 | P19174, P07766, P20963, P09693, P06239, P42224, O60603, P10747, Q04759, Q9HC35, P01730 | PLCG1, CD3E, CD247, CD3G, LCK, STAT1, TLR2, CD28, PRKCQ, EML4, CD4 | More | |
| Testosterone-undecanoate | hsa05321 | Inflammatory bowel disease | 1.17E-03 | 5 | O60603, P13765, Q14765, Q9UL17, P23771 | TLR2, HLA-DOB, STAT4, TBX21, GATA3 | More | |
| Testosterone-undecanoate | hsa05322 | Systemic lupus erythematosus | 2.75E-02 | 3 | P62807, Q16778, P12814 | HIST1H2BC, HIST2H2BE, ACTN1 | More | |
| Testosterone-undecanoate | hsa05323 | Rheumatoid arthritis | 1.60E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | |
| Testosterone-undecanoate | hsa05332 | Graft-versus-host disease | 3.45E-03 | 4 | P13765, P10747, P26715, Q13241 | HLA-DOB, CD28, KLRC1, KLRD1 | More | |
| Testosterone-undecanoate | hsa05340 | Primary immunodeficiency | 4.24E-02 | 3 | P01730, P07766, P06239 | CD4, CD3E, LCK | More | |
| Testosterone-undecanoate | hsa05415 | Diabetic cardiomyopathy | 4.23E-02 | 2 | P30405, P37173 | PPIF, TGFBR2 | More | |
